📋 FDA Reference

Modification to Medamicus Axia Rsn

Medamicus

Compare similar devices

Summary: The Modification to Medamicus Axia RSN is an embolization coil used in interventional radiology to treat vascular abnormalities. It is primarily used by interventional radiologists in hospital settings.

FDA Clearance Information

Pathway ? 510(k)
Number ? K022689 ↗
Decision Date ? August 23, 2002
Product Code ? DYB
Device Class ? Class 2
Evidence ? 0 studies

The device was cleared through the FDA 510(k) pathway on August 23, 2002, by Medamicus. It is classified as a Class 2 medical device under product code DYB.

What It Is

The Modification to Medamicus Axia RSN is an embolization coil designed to occlude blood vessels. It works by being delivered via a catheter to the target site, where it expands and induces clot formation, effectively blocking blood flow. This device is used to treat conditions such as aneurysms or arteriovenous malformations.

FDA-Cleared Indications

  • Use in embolization procedures to occlude selected blood vessels.
  • Treatment of vascular abnormalities that require catheter-based vessel occlusion.

Clinical Applications

  • Embolization of selected abnormal blood vessels.
  • Catheter-based treatment of aneurysms requiring vessel occlusion.
  • Embolization of arteriovenous malformations requiring blockage of abnormal blood flow.

Reported off-label uses

  • Coil embolization of selected bleeding arteries, such as gastrointestinal or bronchial arteries, may be performed in clinical practice depending on the device labeling, anatomy, and physician judgment.
  • Embolization of selected pelvic or visceral vessels may be performed for conditions such as varicocele, uterine bleeding, or organ-directed procedures, but these uses should not be assumed to be specifically cleared for this device.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The coil is delivered through a compatible catheter under fluoroscopic or other appropriate imaging guidance; the treating specialist selects the coil and catheter size based on vessel anatomy.
  • Available sizes and delivery-system compatibility should be confirmed in the current manufacturer instructions for use before the procedure.
  • Potential risks include non-target embolization, vessel injury, bleeding, infection, ischemia, device migration, and incomplete or recurrent occlusion.
  • MRI safety and conditional-use information must be confirmed in the current device labeling; do not assume that an embolization coil is MR safe without that documentation.
  • Use may be inappropriate in patients with an unsafe vascular access route, uncontrolled infection, severe contrast allergy that cannot be managed, or anatomy that does not permit safe catheter and coil placement.

Procedures that use this device

Frequently Asked Questions

What is the Modification to Medamicus Axia RSN used for?

It is used for embolization procedures to occlude blood vessels in conditions like aneurysms and arteriovenous malformations.

What specialties typically use this device?

Interventional radiologists primarily use this device in hospital settings, particularly in radiology departments or catheterization labs.

What are the FDA-cleared indications?

The device is indicated for embolization procedures to treat vascular abnormalities such as aneurysms and arteriovenous malformations.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you